GRAL GRAIL, Inc.
$150.61▲ +7.65%
Healthcare
Other
After hours
$150.61▲ +0.00%
Oct 27, 4:53 PM ET
Volume 1.93M
Avg Volume (10D) 757.1K
Key Metrics & Fundamentals
Market Cap
$6.73B
P/E Ratio
–
Div Yield
0.00%
52W Range
41.50 - 166.48
% vs 50 MA
40.44%
% vs 200 MA
94.78%
RSI-14
65.4
MACD Histogram
-0.8100
Beta (1Y vs SPY)
2.86
Free Cash Flow
-$81.16M
Gross Rev
$44.69M
Gross Profit
-$12.57M
EBITDA
-$84.25M
COGS
$57.25M
Operating Exp
$135.79M
Operating Income
-$148.36M
EBIT
-$148.36M
Pretax Income
-$166.71M
Net Income
-$110.25M
EPS (Diluted)
-2.56
Price & Volume History
Loading chart…
Recent News
GRAIL to Present at the UBS Global Healthcare Conference
PR Newswire · Oct 27, 2026 4:02 PM ET
5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
MarketBeat · Oct 26, 2026 1:15 PM ET
What GRAIL (GRAL)'s Canada Test Rollout Means For Shareholders
Simply Wall St. · Oct 24, 2026 5:13 AM ET
IBD Stock Of The Day, Natera, Hovering Near Buy Point
Investor's Business Daily · Oct 22, 2026 5:40 PM ET
GRAIL to Announce Third Quarter 2026 Financial Results
PR Newswire · Oct 21, 2026 4:02 PM ET
GRAIL (GRAL) Stock Sees Fair Value Lift After Analysts Back Galleri Outlook
Simply Wall St. · Oct 16, 2026 9:13 PM ET
TD Cowen Adjusts GRAIL Price Target to $188 From $88, Maintains Buy Rating
MT Newswires · Oct 13, 2026 8:56 AM ET
Grail Stock Hit a 12-Month High After Its FDA Panel Win. But Here's the Risk Investors Shouldn't Ignore.
Motley Fool · Oct 11, 2026 4:31 AM ET
Jim Cramer Breaks Down the Stakes in Detail as GRAIL (GRAL) Awaits Its Next Big Decision
Insider Monkey · Oct 10, 2026 11:26 AM ET
Grail (GRAL) vs Guardant Health (GH): Which is a Better Stock to Buy?
Insider Monkey · Oct 9, 2026 11:38 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See GRAL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.